Hyperprolinemia

Jump to navigation Jump to search
Hyperprolinemia
L-proline-skeletal.png
Proline
ICD-10 E72.5
ICD-9 270.8
OMIM 239500
DiseasesDB 29674

WikiDoc Resources for Hyperprolinemia

Articles

Most recent articles on Hyperprolinemia

Most cited articles on Hyperprolinemia

Review articles on Hyperprolinemia

Articles on Hyperprolinemia in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hyperprolinemia

Images of Hyperprolinemia

Photos of Hyperprolinemia

Podcasts & MP3s on Hyperprolinemia

Videos on Hyperprolinemia

Evidence Based Medicine

Cochrane Collaboration on Hyperprolinemia

Bandolier on Hyperprolinemia

TRIP on Hyperprolinemia

Clinical Trials

Ongoing Trials on Hyperprolinemia at Clinical Trials.gov

Trial results on Hyperprolinemia

Clinical Trials on Hyperprolinemia at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hyperprolinemia

NICE Guidance on Hyperprolinemia

NHS PRODIGY Guidance

FDA on Hyperprolinemia

CDC on Hyperprolinemia

Books

Books on Hyperprolinemia

News

Hyperprolinemia in the news

Be alerted to news on Hyperprolinemia

News trends on Hyperprolinemia

Commentary

Blogs on Hyperprolinemia

Definitions

Definitions of Hyperprolinemia

Patient Resources / Community

Patient resources on Hyperprolinemia

Discussion groups on Hyperprolinemia

Patient Handouts on Hyperprolinemia

Directions to Hospitals Treating Hyperprolinemia

Risk calculators and risk factors for Hyperprolinemia

Healthcare Provider Resources

Symptoms of Hyperprolinemia

Causes & Risk Factors for Hyperprolinemia

Diagnostic studies for Hyperprolinemia

Treatment of Hyperprolinemia

Continuing Medical Education (CME)

CME Programs on Hyperprolinemia

International

Hyperprolinemia en Espanol

Hyperprolinemia en Francais

Business

Hyperprolinemia in the Marketplace

Patents on Hyperprolinemia

Experimental / Informatics

List of terms related to Hyperprolinemia


Hypeprolinemia, also referred to as prolinemia or prolinuria, is a condition which occurs when the amino acid proline is not broken down properly by the enzymes proline oxidase or pyrroline-5-carboxylate dehydrogense, causing a build up of proline in the body.

Types

Hyperprolinemia type I

It is difficult to determine the prevalence of hyperprolinemia type I, as many people with the condition are asymptomatic.[1] People with hyperprolinemia type I have proline levels in their blood between 3 and 10 times the normal level. Some individuals with type I exhibit seizures, mental retardation or other neurological problems.[1]

Hyperprolinemia type II

Hyperprolinemia type II results in proline levels in the blood between 10 and 15 times higher than normal, and high levels of a related compound called pyrroline-5-carboxylate. This rare form of the disorder may appear benign at times,[2] but often involves seizures, convulsions, and mental retardation.[1]

Hyperprolinemia can also occur with other conditions, such as malnutrition or liver disease. In particular, individuals with conditions that cause elevated levels of lactic acid in the blood, such as lactic acidemia, are likely to have elevated proline levels, because lactic acid inhibits the breakdown of proline.[1]

Genetics

Hyperprolinemia has an autosomal recessive pattern of inheritance.

Mutations in the ALDH4A1 and PRODH genes cause hyperprolinemia.[1]

Hyperprolinemia type I is caused by a mutation in the PRODH gene, which codes for the enzyme proline oxidase. This enzyme begins the process of degrading proline by starting the reaction that converts it to pyrroline-5-carboxylate.

Hyperprolinemia type II is caused by a mutation in the ALDH4A1 gene, for the enzyme pyrroline-5-carboxylate dehydrogenase. This enzyme helps to break down the pyrroline-5-carboxylate produced in the previous reaction, converting it to the amino acid glutamine. The conversion between proline and glutamine, and the reverse reaction controlled by different enzymes, are important factors required to maintain proper metabolism and protein production.

A deficiency of either proline oxidase or pyrroline-5-carboxylate dehydrogenase results in a buildup of proline in the body. A deficiency of the latter enzyme leads to higher levels of proline and a buildup of the intermediate breakdown product pyrroline-5-carboxylate, causing the signs and symptoms of hyperprolinemia type II.

Hyperprolinemia is inherited in an autosomal recessive pattern, which means two copies of the gene in each cell are altered. Most often, the parents of an individual with an autosomal recessive disorder are heterozygous carriers, having only one copy of the altered gene, without having signs and symptoms of the disorder.

In about one-third of cases of hyperprolinemia, individuals carrying one copy of an altered PRODH gene have moderately elevated levels of proline in their blood, but these levels do not cause any health problems.[1] Individuals with one altered ALDH4A1 gene have normal levels of proline in their blood.

Research

A 2005 study on rats suggested that hyperprolininemia causes cognitive dysfunction.[3]

See also

External links

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 http://ghr.nlm.nih.gov/condition=hyperprolinemia
    Genetics Home Reference - Hyperprolinemia
  2. Onenli-Mungan N, Yuksel B, Elkay M, Topaloglu AK, Bakal T, Ozer G (2004). "Type II hyperprolinemia: a case study". Turk J Pediatr. 46 (2): 167–169. PMID 15214748.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  3. Bavaresco CS, Streck EL, Netto CA, Wyse AT (2005). "Chronic hyperprolinemia provokes a memory deficit in the Morris water maze task". Metab Brain Dis. 20 (1): 73–80. PMID 15918552.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>

Template:WH Template:WS